artificial intelligence
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
The health startup provides telemedicine services for insurance companies, corporations and government entities.
The risk assessment tool can potentially determine if plaque build-up has narrowed a patient's coronary arteries.
The technology can detect 588 common and rare skin conditions in 133 categories.
The study also found that applying a federated learning approach can further improve accuracy of the model.
The collaboration will use AI technology to accelerate the drug discovery process.
The companies will develop a solution based on a new technique of flow cytometry that enables fast and accurate cell analysis using AI.
SPONSORED
|
04:21 pm |
May 11, 2021
|
04:21 pm |
May 11, 2021
Health systems need an omnichannel patient engagement platform that uses sophisticated AI technology and integrates well with their back-end systems, says Nuance Chief Strategy Officer Peter Durlach.
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection.
The company states that the study was designed to minimise bias in assessing the solution’s impact on diagnostic accuracy.